Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 181.47% | 186.21% | |
| Total Depreciation and Amortization | -- | -- | 86.61% | 258.78% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -1,365.35% | 295.22% | |
| Change in Net Operating Assets | -- | -- | -- | -- | |
| Cash from Operations | -- | -- | 406.23% | 7,775.86% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 1,099.02% | 147.55% | |
| Cash from Investing | -- | -- | 360.05% | -1,014.80% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 6,135.71% | -49.34% | |
| Cash from Financing | -- | -- | -9,697.28% | -766.64% | |
| Foreign Exchange rate Adjustments | -- | -- | -115.76% | -153.98% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | 493.00% | -654.07% | |